Congress Platform

ESMO events

All news

Congress

Date

Reset

topics

Cancer Immunology and Immunotherapy Head and neck cancers Lung and other thoracic tumours Precision oncology

Search results (12)

2022_public 3

Lung and other thoracic tumours

7 Dec 2022

Exploratory analysis of IMpower010 confirms that ctDNA is prognostic for adjuvant atezolizumab in NSCLC

Read more

IO_2022_01

Lung and other thoracic tumours

7 Dec 2022

Neoadjuvant anti-PD-L1/TGFβRII fusion protein facilitates surgery in unresectable NSCLC

Read more

Jean-Pascal Machiels

Cancer Immunology and Immunotherapy

7 Dec 2022

Is combining radiotherapy and immunotherapy a viable treatment option?

Conflicting clinical results on the benefits of combined radiotherapy and immunotherapy may derive from differences in treatment sequencing

By Jean-Pascal Machiels

Read more

Stephen P. Schoenberger

Cancer Immunology and Immunotherapy

7 Dec 2022

Is there still a future for cancer vaccines?

Despite generally disappointing clinical trial results, technological innovations mean that realising the potential for cancer vaccines could be just around the corner

By Stephen P. Schoenberger

Read more

DR_mobile_FOR EDITORIALS

Cancer Immunology and Immunotherapy

7 Dec 2022

Back to basics: do we need more immuno-oncology in the core curriculum?

By

Alessandra Curioni Fontecedro

Read more

Public 6

Lung and other thoracic tumours

8 Dec 2022

Two studies explore new predictive biomarkers for immunotherapy in NSCLC

Read more

IO2022_5

Precision oncology

8 Dec 2022

Combined biomarker analysis shows promise as a tissue agnostic response predictor for immunotherapy-based treatment

Read more

IO2022_3

Lung and other thoracic tumours

7 Dec 2022

Neoadjuvant camrelizumab plus chemotherapy improves pathologic complete response in stage IIIA and B NSCLC

Read more

IO2022_4

Cancer Immunology and Immunotherapy

8 Dec 2022

Do immune checkpoint inhibitors affect COVID-19 severity?

Read more

IO2022_Award

Cancer Immunology and Immunotherapy

7 Dec 2022

Nina Bhardwaj receives the ESMO Immuno-Oncology Award 2022

Read more

1 of 2
2

Daily Reporter

Twitter
Facebook
Youtube
RSS
LinkedIn
Instagram

30169140e251db563e46719de7ec91e4

ESMO is a Swiss-registered not-for-profit organisation. All funding for this site is provided directly by ESMO. Via Ginevra 4, 6900 Lugano – CH

© Copyright 2023 European Society for Medical Oncology
All rights reserved worldwide.

Home
Editorial Board
All Editions

Privacy Policy
ESMO Website

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

Necessary cookies
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.